We’re excited to announce that PRECISIONvalue has been shortlisted for a 2020 MM&M award along with Takeda Oncology in the Use of Market Access Marketing category! And congratulations to our colleagues at PRECISIONeffect for their finalist nomination in the TV Advertising Campaign category.
Congratulations to the team for being listed as one of the top healthcare agencies of 2020 by MedAd News!
This June marks the 8th annual Cancer Immunotherapy Month led by the Cancer Research Institute to raise awareness of lifesaving immunotherapies. To help support, PRECISIONvalue got together to raise awareness for Immune2Cancer Day, wearing white for everyone working behind the scenes actively working on treatments for all forms of cancer. We are proud at Precision to support our partners in their drive to shape the future of immune-based science and medicine for cancer treatments, and ultimately, cures.
Congratulations to Precision’s Jason Shafrin! For the third consecutive year, Jason’s blog, Healthcare Economist, has been listed as one of the Top 100 Economics Blogs by Intelligent Economist.
Congratulations to our three(!) Precision Value & Health leaders for each winning 2020 PM360 ELITE 100 Awards!
PRECISIONvalue’s Jeremy Schafer won the Strategist Award, PRECISIONeffect’s Heather O’Handley won the Sales MVP Award, and PRECISIONscientia’s Nicole Ramocki won the Launch Expert Awards.
REBRANDING LAUNCH EMPHASIZES COMPANY’S INVESTMENT AND PRIORITY IN UNIFYING EXPERTISE AND ACCELERATING CULTURE OF COLLABORATION
New York, NY – April 7th, 2020 – Precision Value & Health, part of Precision Medicine Group, today announced a comprehensive rebranding that includes new names, new logos and updated positioning to accurately reflect its expanded offerings in 2020. To communicate this new positioning and re-aligned capabilities, the company has also rolled out new websites for Precision Value & Health as well as its sub-brands.
How much of a roll can pharmaceutical manufacturers play in the social determinants of health? Industry experts, Maureen Hennessey, PhD, and Dominic Galante, MD, discuss how much they can stand to gain in medication adherence and outcomes from partnering with other industry stakeholders and programs around the issue.
Read the full article below.
There’s a simple reason why co-pay accumulators captured the industry’s attention when they rolled out in 2017: Healthcare is too damn expensive and co-pay accelerators, at least in theory, offered a financial workaround.
Read the full article here.
A focus on value-based care and other market drivers have led to the development of trendsetters, entrants and disruptors (TEDs). Precision for Value’s Dr. Oyekan and Jorge Font, discuss the five main archetypes of TEDs.
Read the full article here.
Precision medicine is a potential game-changer and oncology expert Jeremy Schafer offers four ways that he believes precision medicine will change cancer treatment.
Read the full article here.
